TKNO 7.33 Stock Price Alpha Teknova, Inc.
Range: | 1.155-8.36 | Vol Avg: | 225651 | Last Div: | 0 | Changes: | 0.05 |
Beta: | 0.36 | Cap: | 0.39B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Fri Jun 25 2021 | Empoloyees: | 210 |
CUSIP: | 02080L102 | CIK: | 0001850902 | ISIN: | US02080L1026 | Country: | US |
CEO: | Mr. Stephen Gunstream | Website: | https://www.teknova.com |
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.